BioSyent Inc.
BIOYF
$8.81
$0.657.97%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 13.33% | 12.80% | 9.17% | 11.08% | 16.55% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 13.33% | 12.80% | 9.17% | 11.08% | 16.55% |
| Cost of Revenue | 22.15% | 23.62% | 17.93% | 23.59% | 33.61% |
| Gross Profit | 11.10% | 10.16% | 7.12% | 8.24% | 12.89% |
| SG&A Expenses | 31.85% | 33.17% | 28.84% | 6.91% | 7.14% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 35.48% | 37.09% | 32.69% | 10.96% | 13.16% |
| Operating Income | 47.74% | 43.17% | 46.71% | 11.44% | 28.30% |
| Income Before Tax | 13.86% | 9.04% | 12.87% | 11.58% | 29.23% |
| Income Tax Expenses | 19.63% | 14.47% | 19.21% | 6.37% | 18.54% |
| Earnings from Continuing Operations | 11.99% | 7.27% | 10.83% | 13.36% | 33.13% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 11.99% | 7.27% | 10.83% | 13.36% | 33.13% |
| EBIT | 47.74% | 43.17% | 46.71% | 11.44% | 28.30% |
| EBITDA | 50.35% | 46.40% | 49.52% | 10.12% | 26.68% |
| EPS Basic | 15.25% | 10.58% | 14.09% | 16.74% | 37.68% |
| Normalized Basic EPS | 45.15% | 40.92% | 47.62% | 14.90% | 33.60% |
| EPS Diluted | 14.96% | 10.28% | 14.04% | 16.76% | 38.10% |
| Normalized Diluted EPS | 44.70% | 40.59% | 47.51% | 14.92% | 33.88% |
| Average Basic Shares Outstanding | -2.76% | -3.01% | -3.05% | -3.05% | -3.32% |
| Average Diluted Shares Outstanding | -2.48% | -2.84% | -3.05% | -3.12% | -3.50% |
| Dividend Per Share | 8.37% | 8.50% | 10.79% | 8.42% | 41.17% |
| Payout Ratio | -0.06% | -0.02% | -0.03% | -0.07% | 0.03% |